Cargando…
Evolving pharmacovigilance requirements with novel vaccines and vaccine components
This paper explores the pipeline of new and upcoming vaccines as it relates to monitoring their safety. Compared with most currently available vaccines, that are constituted of live attenuated organisms or inactive products, future vaccines will also be based on new technologies. Several products th...
Autores principales: | Zuber, Patrick L F, Gruber, Marion, Kaslow, David C, Chen, Robert T, Giersing, Brigitte K, Friede, Martin H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137242/ https://www.ncbi.nlm.nih.gov/pubmed/34011500 http://dx.doi.org/10.1136/bmjgh-2020-003403 |
Ejemplares similares
-
Novel vaccine safety issues and areas that would benefit from further research
por: Salmon, Daniel A, et al.
Publicado: (2021) -
Vaccine safety issues at the turn of the 21st century
por: Conklin, Laura, et al.
Publicado: (2021) -
The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
por: Maure, Christine G, et al.
Publicado: (2014) -
Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010) -
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015()
por: Giersing, Birgitte K., et al.
Publicado: (2016)